Circulating plasma angiotensin-converting enzyme 2 concentrations in patients with kidney disease.
作者信息
Schmidt Insa M, Verma Ashish, Waikar Sushrut S
机构信息
Department of Medicine, Section of Nephrology, Boston University Medical Center, 650 Albany Street, Boston, MA 02118, USA.
Department of Medicine, Renal Medicine Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA.
出版信息
Eur Heart J. 2020 Jul 1;41(32):3097-3098. doi: 10.1093/eurheartj/ehaa523.
Abstract
摘要
相似文献
1
Circulating plasma angiotensin-converting enzyme 2 concentrations in patients with kidney disease.肾病患者循环血浆中血管紧张素转换酶2的浓度
Eur Heart J. 2020 Jul 1;41(32):3097-3098. doi: 10.1093/eurheartj/ehaa523.
2
Angiotensin-converting enzyme type 2 and aldosterone synthesis: beyond the renin--angiotensin--aldosterone system and closer to the clinic.2型血管紧张素转换酶与醛固酮合成：超越肾素-血管紧张素-醛固酮系统，更贴近临床
J Hypertens. 2021 Aug 1;39(8):1546-1548. doi: 10.1097/HJH.0000000000002858.
3
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?心力衰竭中肾素-血管紧张素-醛固酮系统激活的生物标志物：有多大用处，多可行？
Clin Chim Acta. 2015 Mar 30;443:85-93. doi: 10.1016/j.cca.2014.10.031. Epub 2014 Oct 25.
4
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.男性和女性心力衰竭患者中血管紧张素转换酶 2 的循环血浆浓度及其对肾素-血管紧张素-醛固酮抑制剂的影响。
Eur Heart J. 2020 May 14;41(19):1810-1817. doi: 10.1093/eurheartj/ehaa373.
5
The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.清醒犬充血性心力衰竭时的肾素-血管紧张素-醛固酮系统
J Clin Invest. 1976 Jun;57(6):1606-17. doi: 10.1172/JCI108431.
6
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.卡托普利治疗：肾素、血管紧张素I和II、醛固酮及血压的剂间变化
Br J Clin Pharmacol. 1982 Jun;13(6):855-8. doi: 10.1111/j.1365-2125.1982.tb01878.x.
7
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry.揭示高钾血症、肾素-血管紧张素-醛固酮抑制剂使用与临床结局之间的相互作用。来自 ESC-HFA-EORP 心力衰竭长期注册研究的 9222 例慢性心力衰竭患者的数据。
Eur J Heart Fail. 2020 Aug;22(8):1378-1389. doi: 10.1002/ejhf.1793. Epub 2020 Apr 3.
8
The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats.
J Hypertens Suppl. 1983 Oct;1(1):37-40.
9
[Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].[自发性高血压大鼠中血管紧张素转换酶抑制血管紧张素I时的肾组织血管紧张素]
Arch Mal Coeur Vaiss. 1997 Aug;90(8):1135-41.
10
[An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].血管紧张素转换酶抑制剂（卡托普利）长期给药对血压及肾素 - 血管紧张素 - 醛固酮系统影响的实验研究（作者译）
Nihon Naibunpi Gakkai Zasshi. 1980 Jun 20;56(6):868-83. doi: 10.1507/endocrine1927.56.6_868.
引用本文的文献
1
Circulating angiotensin converting enzyme 2 and COVID-19.循环血管紧张素转换酶2与新型冠状病毒肺炎
World J Clin Cases. 2022 Dec 6;10(34):12470-12483. doi: 10.12998/wjcc.v10.i34.12470.
2
Angiotensin-(1-7)-A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic.血管紧张素-（1-7）：急性肾损伤的潜在治疗方法——从新冠疫情中获得的见解
J Clin Med. 2021 Mar 13;10(6):1200. doi: 10.3390/jcm10061200.
3
Understanding COVID-19: in the end it is the endothelium-what else?了解新型冠状病毒肺炎：归根结底是内皮细胞的问题——还能有什么别的呢？
Eur Heart J. 2020 Aug 21;41(32):3023-3027. doi: 10.1093/eurheartj/ehaa706.
4
Circulating plasma angiotensin-converting enzyme 2 concentration is elevated in patients with kidney disease and diabetes.肾病和糖尿病患者循环血浆血管紧张素转换酶2浓度升高。
Eur Heart J. 2020 Jun 1;41(32):3099. doi: 10.1093/eurheartj/ehaa527.
本文引用的文献
1
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.糖尿病与2019冠状病毒病的死亡率及严重程度相关吗？一项荟萃分析。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):535-545. doi: 10.1016/j.dsx.2020.04.044. Epub 2020 May 6.
2
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.男性和女性心力衰竭患者中血管紧张素转换酶 2 的循环血浆浓度及其对肾素-血管紧张素-醛固酮抑制剂的影响。
Eur Heart J. 2020 May 14;41(19):1810-1817. doi: 10.1093/eurheartj/ehaa373.
3
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.肾素-血管紧张素-醛固酮系统阻滞剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1.
4
Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection.慢性肾脏病与2019冠状病毒病（COVID-19）严重感染相关。
Int Urol Nephrol. 2020 Jun;52(6):1193-1194. doi: 10.1007/s11255-020-02451-9. Epub 2020 Mar 28.
5
The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.原发性肾脏活检组织学病变的预后价值：来自波士顿肾脏活检队列研究的结果。
J Am Soc Nephrol. 2018 Aug;29(8):2213-2224. doi: 10.1681/ASN.2017121260. Epub 2018 Jun 4.
Zotero 插件